2025-07-23 - Analysis Report
Okay, here's a report summarizing the provided information about Colgate-Palmolive Co (CL), including analysis and key takeaways.

**Report: Colgate-Palmolive Co (CL) Analysis**

**0. Executive Summary**

Colgate-Palmolive (CL) shows underperformance compared to the S&P 500 (VOO) with a significant lag in cumulative return. Recent volatility and mixed signals from technical indicators alongside negative expected returns suggest caution. However, recent news indicates active market interest and analyst discussions, requiring further investigation.

**1. Relative Performance Analysis**

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co -  A global consumer products company focusing on oral care, personal care, home care, and pet nutrition.
*   **CL Cumulative Return:** 14.78%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Divergence:** -83.1 (Max: 7.9, Min: -83.1)
*   **Relative Divergence:** 0.0

**Analysis:**  CL has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The relative divergence being at its minimum (0.0) indicates that the underperformance is at its worst point within the observed range.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha    | Beta  | Cap(B) |
|------------|---------|---------|----------|-------|--------|
| 2015-2017  | 13.0%   | 4.5%    | -16.0%   | 0.0   | 61.1   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%   | 0.1   | 48.2   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%   | 0.1   | 55.8   |
| 2018-2020  | 18.0%   | 65.2%   | -2.0%    | 0.6   | 69.3   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%   | 0.7   | 69.2   |
| 2020-2022  | 7.0%    | 69.0%   | 5.0%     | 0.7   | 63.9   |
| 2021-2023  | 6.0%    | 69.0%   | -12.0%   | 0.8   | 64.6   |
| 2022-2024  | 13.0%   | 69.0%   | -12.0%   | 0.8   | 73.7   |
| 2023-2025  | 2.0%    | 70.6%   | -47.0%   | 0.3   | 71.9   |

**Analysis:**

*   **Alpha:**  The negative alpha values in most periods suggest that CL has generally underperformed its benchmark on a risk-adjusted basis. The large negative alpha in the 2023-2025 period is particularly concerning.
*   **Beta:** The low Beta values (0.0-0.8) indicate that CL's price is not strongly correlated with the S&P 500.  It suggests CL is less sensitive to overall market movements.
*   **CAGR:** The fluctuating CAGR values indicates inconsistent annual growth rates over the past decade, with low growth in the most recent period.
*   **MDD:** The high Maximum Drawdown (MDD) values suggest high potential for loss in investment during those periods.
*   **Cap(B):** The market capitalization varies in the range of $48.2 Billion to $73.7 Billion

**2. Recent Price Action**

*   **Current Price:** 88.70
*   **Previous Close:** 86.64
*   **Price Change:** 2.38
*   **5-day Moving Average:** 87.42
*   **20-day Moving Average:** 89.56
*   **60-day Moving Average:** 90.39

**Analysis:**  The current price shows a recent upward movement compared to the previous close, with a change of 2.38. The price is below both the 20-day and 60-day moving averages, suggesting a short-term downtrend, but above the 5-day MA. The recent rise in price indicates a possible short-term recovery.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 33.79
*   **PPO:** -0.34
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **Delta_Previous_Relative_Divergence:** 0.0 (Negative) - Short-term decline.
*   **Expected Return:** -3606.6%

**Analysis:**

*   **MRI:** The MRI indicates low market risk, which is a positive factor for investment stability.
*   **RSI:** The RSI is below 30, suggesting that the stock may be oversold, potentially indicating a buying opportunity.
*   **PPO:** The negative PPO value indicates that the stock price is trading below its moving average, supporting a bearish trend.
*   **Hybrid Signal:** The Hybrid Signal recommends selling a significant portion of holdings and increasing the cash ratio, which is a bearish signal.
*   **Delta_Previous_Relative_Divergence:** Short-term decline indicates a weakening position compared to its benchmark.
*   **Expected Return:** The extremely negative expected return suggests a highly unfavorable outlook for long-term investment in CL compared to the S&P 500.

The recent price increase combined with an oversold RSI could indicate a short-term bounce, but the overall technical picture remains bearish, especially given the negative expected return.

**4. Recent News & Significant Events**

*   **[2025-07-23]:** Colgate-Palmolive Co (CL) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-22]:** Analysts are discussing Colgate-Palmolive Co's (CL) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-20]:** Colgate-Palmolive Co (CL)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-21]:** Market experts highlight both risks and opportunities for Colgate-Palmolive Co (CL), advising investors to monitor recent news and company announcements.

**Analysis:** The news highlights recent volatility and active discussion surrounding CL. It's crucial to investigate these news items further to understand the drivers behind the market movements and analyst sentiment.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-04-25 | 0.85  | 4.91 B$   |
| 2024-10-25 | 0.90  | 5.03 B$   |
| 2024-07-26 | 0.89  | 5.06 B$   |
| 2024-04-26 | 0.83  | 5.07 B$   |
| 2025-04-25 | 0.83  | 5.07 B$   |

**Analysis:**  The EPS and revenue figures have been relatively stable over the recent quarters. There's a slight decrease in revenue in the most recent quarter. EPS has also slightly declined. Overall, earnings performance is consistent but doesn't show significant growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $4.91B    | 60.82%        |
| 2024-12-31 | $4.95B    | 60.30%        |
| 2024-09-30 | $5.03B    | 61.08%        |
| 2024-06-30 | $5.06B    | 60.62%        |
| 2024-03-31 | $5.07B    | 60.00%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $0.36B    | 190.08%   |
| 2024-12-31 | $0.21B    | 348.58%   |
| 2024-09-30 | $0.43B    | 169.43%   |
| 2024-06-30 | $0.12B    | 594.31%   |
| 2024-03-31 | $0.23B    | 296.96%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has shown a slight decline in the most recent quarter. The profit margin has remained relatively stable, hovering around 60%. The consistent profit margin suggests effective cost management.
*   **Capital and Profitability:**  The Equity values fluctuate significantly over the quarters. The Return on Equity (ROE) is exceptionally high, suggesting the company is generating substantial profits from its equity. However, the fluctuating Equity values raise questions about capital management and require further investigation.

**7. 종합적인 분석 (Overall Analysis)**

Colgate-Palmolive Co (CL) has underperformed significantly compared to the S&P 500. Technical indicators show a mixed picture, with an oversold RSI potentially signaling a short-term buying opportunity, but negative PPO and expected returns suggest a bearish outlook.

Recent news indicates increased market activity and analyst discussions surrounding CL. The stable revenue and profit margins provide some reassurance, but the fluctuating equity values and negative long-term expected returns are concerning.

**Recommendation:**

Given the underperformance relative to the S&P 500, negative long-term return projections, and bearish technical signals, a **cautious or even bearish** stance may be warranted.  A deeper investigation into the reasons behind the underperformance, recent news events, and equity fluctuations is recommended before making any investment decisions. Monitor the stock closely for any fundamental changes or positive catalysts that could alter the outlook. Consider the hybrid signal's recommendation to reduce holdings.
